Latest News

STAT Plus: Pharmalittle: A move to fund U.S. production of pharma ingredients; White House issues ‘principles’ for drug pricing reform

Good morning, everyone, and how are you today? We are coping, thank you, despite the raging tumult underway beyond the walls of the Pharmalot campus. For those needing a moment of relief, allow us to pass along a quip from years past: When told the sky was falling, Chicken Little had but one reaction: Sell sky! And now, on with the show. Time for a cup of stimulation and a look at the to-do list. Hope your day goes well and you remain healthy.

In response to the novel coronavirus and drug shortages in general, two senators introduced a bill to funnel $100 million to increase U.S. production of medicines and active pharmaceutical ingredients, CNBC says. The legislation sponsored by Marsha Blackburn, R-Tenn., and Bob Menendez, D-N.J., would expand upon the Emerging Technology Program within the Food and Drug Administration to prioritize issues related to national security and critical drug shortages, as well as bring pharmaceutical manufacturing jobs to the U.S.

Continue to STAT Plus to read the full story…

Source link

Related posts

Three ways to use KASPER to protect your practice


Rheumatoid arthritis linked to other diseases before and after diagnosis, shows study


Toothpaste And Mouthwash Use May Cause Antibiotic Resistance


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy